rs10774021

This is a intron variant variant in the SLC6A13 gene.

GWAS Catalog Trait Associations (15)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

deoxycarnitine measurement

Allele T
OR 0.35
p 1.0e-241
N 14,296
Large GWAS
European
Allele T
OR 0.35
p 1.0e-138
N 8,809
Large GWAS
European
Allele T
OR 0.35
p 3.0e-135
N 8,271
Large GWAS
European
Allele T
OR 0.10
p 1.0e-43
N 4,960
Large GWAS
European

1-methylimidazoleacetate measurement

Allele T
OR 0.35
p 2.0e-232
N 14,296
Large GWAS
European
Allele T
OR 0.35
p 1.0e-109
N 8,809
Large GWAS
European

1-methyl-4-imidazoleacetate measurement

Allele T
OR 0.36
p 5.0e-125
N 8,090
Large GWAS
European

3-aminoisobutyrate measurement

Allele T
OR 0.23
p 2.0e-106
N 14,296
Large GWAS
European

imidazole lactate measurement

Allele T
OR 0.21
p 2.0e-90
N 14,296
Large GWAS
European
Allele T
OR 0.19
p 1.0e-34
N 8,256
Large GWAS
European

glutamine measurement

Allele T
OR 0.15
p 1.0e-27
N 8,293
Large GWAS
European

X-25419 measurement

Allele T
OR 0.19
p 5.0e-22
N 6,136
Large GWAS
European

serum creatinine amount

Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele C
OR 0.02
p 2.0e-17
N 602,615
Major Consortium StudyLarge GWAS
multi-ancestry
Allele C
OR 0.02
p 7.0e-15
N 153,950
Large GWAS
East Asian
Karjalainen MK et al. Genome-wide characterization of circulating metabolic biomarkers. Nature 628(8006):130-138 (2024)
Allele C
OR 0.03
p 6.0e-13
N 136,016
Large GWAS
multi-ancestry

About SLC6A13

Enables gamma-aminobutyric acid:sodium:chloride symporter activity. Involved in amino acid import across plasma membrane and monocarboxylic acid transport. Located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]

View all SLC6A13 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…